I am a former PhD scientist-turned-writer focused on cancer education. My writings in Seeking Alpha have been devoted to helping people identify promising investment opportunities in cancer research through commentary of recent events. Readers can learn more about other aspects of cancer research by visiting my site Invest Against Cancer.
I also collaborate with Avisol Capital Partners on their Marketplace service known as the Total Pharma Tracker (TPT). Some of my work will be available to TPT subscribers either exclusively, or in advance. If you are interested, please click the link above!
To all my followers I welcome you to my BlogSpot at SA....
You PAY nothing to me to learn what I know.. I give it to all FREELY and only ask that you pass it on in your own special way, especially if you MAKE MONEY!
I am now nearly 11 years retired from the US pharma industry having spent over 33 years in the Mid-Atlantic Corridor in Sales (Hospital mainly), Scientific Relations, Managed Care/LTC, than back into sales before retiring at age 55! It was always my Dream to retire Early and I achieved my Dream in May of 2007.
I started in 1974 around Christmas Time...US Pharma was the gift that kept giving to me for almost a Lifetime.I began my career 7 months out of College at tiny Reed and Carnrick, Kenilworth, NJ. We had HIGH double digit INFLATION and soaring Un employment in 1974! After 4 years of on the job learning and thank God for Michael Morse the best Division Sales Mgr I ever had, who believed in me when others thought I was too young and In-experienced, I developed into a Solid Pharma sales performer!
Others took notice and came calling in 1978, I left R&C and went to Hospital Sales at BMY for the next 4.5 years, than in 1983 Bayer/Miles Labs recruited me away, I stayed 25 years at Bayer until we merged into SGP/MRK prior to early retirement in 2007..
I was part of the launch of over 50 new drugs over my Career with 6 different Antibiotics including Azlocillin, Amikacin , Cipro and finally Avelox. The list included Antibiotics, Anti-Fungals, Anti High Blood Pressure/ Cholesterol, Anti-Neoplastics/Cancer, Immune Modulators, Dementia/AZ and Diabetes.etc. I like to say I sold drugs that treated people from WOMB to TOMB and I mean that quite literally!
Today I enjoy investing in Bio-Pharmas mostly, because it is what I know best! I come from the Peter Lynch School of Investing so only Invest in what you Know best!
I invest mostly 70% of portfolio in large companies such as AZN, BMY, PFE, MRK, GSK, and JNJ (love the divis and security) but I like the up and coming riskier Bios like EXEL,EXAS,CLDX, ARRY and many others. Cancer, Immunotherapy and Inflammation intrigues me most today--I call these disease states the FRUIT at the Top, pretty much all the Low hanging Fruit is now discovered and available Generically/relatively cheap too....so I have made those 3 Disease States a major Focus since 2008 w/ plays at PFE, JNJ,BMY,MRK and GSK...my best performing BTs are CRIS and EXEL, which have done quite well over time for me....today I see ARRY as a BT that reminds me so much of EXEL or CRIS a couple years ago....I am long ARRY and many others today!
As of 9/20/17 I am announcing a STRONG BUY on CRIS again....a stock Ive been invested in since 2010 w/ net profit booked of ~$68,000. CRIS is One of many incubators for Roche Holdings and Genentech..they are tiny but very nimble and worthy of risk money!
With the real fears of WW Pandemics and MDR-Bacteria, the FDA/Congress has given us BARDA,the GAIN act and QDIP and I've come to appreciate the Retroviral/Antibiotic/Anti-fungal cos.and have made them a major component of my LT strategy to build wealth while in Retirement....
Ive invested in AB cos like Trius(TSRX), Cubist(CBST), Cempra(CEMP-now Melinta), Durata(DRTX), Tetraphase(TTPH), Innovation(IPIX), Akaogen(AKAO),and Paratek(PRTK)....over the last couple years... I manage personal monies and some family members retirement monies..in total well over $1M ....gratis of course!
Just click on my Picture up in the Top left corner and you can always read my thoughts on a myriad of Pharmas and BTs..I think I have 900+ comments going back 10 years now!
I do not write articles for SA because their Editors do not believe in my Writing Style and I'm too old and unwilling to change for them for a lousy $35/article/penny per click payment so I Blog FREE instead! I give FREELY what others charge an ARM or a LEG for and many read me for just that reason, others for my wisdom and yet others for me experiences in Pharma..I try to keep it REAL WORLD when SA imo does not..in fact I think SA is a fraud promoter for much of their operation!
You may or may not agree w/ me in my postings but I will always tell you how I feel about Companies and I spare you the Noise and PC crap you may hear from others...mine is an opine that covers these Companies from the perspective of ONE who worked for/against them and over 33 years..today I am UN-encumbered by the BRIDLES of employment and PC , I can honestly look back at the those who did it right and wrong and share my thoughts w/ you honestly!
Robert P. Balan has almost 50 years of experience in the financial markets. Education in mining engineering, computer science, finance, and training in economics led to a commodity analysis career during the commodity boom of the early 1970s. Robert made a switch to global macro focus in the early 1980 when the commodity bull market waned, with specialization in foreign exchange. Robert wrote a very high profile daily FX analysis while Geneva-based in the mid-1980s (the first FX commentary with a real global readership, "most accessed" in the Reuters and Telerate networks from 1988 to 1994). He worked for Swiss Bank Corp and Union Bank of Switzerland (precursors of today’s new UBS) as head of technical research and as proprietary trader in various major finance centers (London, New York, and subsequently head of proprietary trading in Toronto, respectively) from late 1980s to mid-1990s. A stint at Bank of America as head of global technical research (in London and New York) followed in late 1990s to early 2000s. Robert did technical analysis for Saxo Bank (Denmark) in the mid-200s based in New York. He returned to Switzerland in 2004 as head of technical research and strategy, and FX and commodity market analyst for Swiss Life Asset Management in Zurich. He joined Diapason Commodities Management in 2008 as senior market strategist, and subsequently as Chief Market Strategist, utilizing fundamental macroeconomic drivers, and structural/technical data in modeling asset price and sector movements. Robert wrote a book on the Elliott Wave Principle in 1988, which was hailed by the London Society of Technical Analysts as “the best book ever written on the subject”. Robert is a member of the National Association for Business Economics (NABE), USA.
I hold a Graduate Diploma in Applied Finance and Investment (similar to CFA), and a Graduate Diploma in Financial Planning.
I have 30 years of personal investing experience, and 18 years of professional financial advising experience. As a global investor I use a macro thematic approach searching for good value and/or high growth. I search the globe for great investments with a focus on "trend investing" themes. Some trends I currently follow include the rising Asian middle class, electric vehicles and the lithium/cobalt/graphite/nickel/copper miners, the online data boom, renewable energy, energy storage (including vanadium), 3D printing, personal robots, and autonomous vehicles.
I also love to invest in income producing investments that can grow over time and benefit from compounding, or help fund retirement income.
I host a Marketplace Service called Trend Investing. Potential new subscribers can learn about my Seeking Alpha Trend Investing subscriber service from the links below:
"The Trend Investing Difference" - Click here.
"Recent Subscriber Feedback On Trend Investing" - Click here.
Seeking Alpha's product team is responsible for the development of all of our product-related projects from start to finish. These projects include the Seeking Alpha Portfolio apps on the App Store and Google Play, our Real Time email alert product, and optimization across the Seeking Alpha website.
The purpose of this profile is to allow us to share with our readers all new product developments. Please follow us on Seeking Alpha to receive updates. We look forward to your input and feedback!
SA Product Team
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Brad Thomas is a research analyst and he currently writes weekly for Forbes and Seeking Alpha where he maintains research on many publicly-listed REITs. In addition, Thomas is the Editor of the Forbes Real Estate Investor, a monthly subscription-based newsletter.
Thomas has also been featured in Forbes Magazine, Kiplinger’s, US News & World Report, Money, NPR, Institutional Investor, GlobeStreet, CNN, Newsmax, and Fox. He is the #1 contributing analyst on Seeking Alpha in 2014, 2015, 2016, and 2017 (based on page views).
Thomas has co-authored a book, The Intelligent REIT Investor, and is the author of The Trump Factor: Unlocking The Secrets Behind The Trump Empire (available on Amazon).
Thomas received a Bachelor of Science degree in Business/Economics from Presbyterian College and he is married with 5 wonderful kids.
Asia Value & Moat Stocks is a research service for value investors seeking value stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e. buying assets at a discount e.g. net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e. buying earnings power at a discount in great companies like "Magic Formula" stocks, high quality businesses, hidden champions and wide moat compounders).
Those who believe that the pendulum will move in one direction forever—or reside at an extreme forever— eventually will lose huge sums. Those who understand the pendulum's behavior can benefit enormously. ~ Howard Marks
Investment ideas for Asia Value & Moat Stocks are generated from screens, insider trades, 13Fs, fund manager letters, analyst reports, blogs and forums. The initial ideas sourced are subsequently evaluated using The Cheapness-Safety-Quality (CSQ) framework, applying customized investment checklists to ask the right questions of the investments in question, along the dimension of cheapness, safety and quality. Asia/U.S. Deep-Value Wide-Moat Stocks' value investing philosophy borrows from the wisdom of value investing gurus, using both quantitative screens and qualitative inputs to filter the global stock markets for investment ideas.
I am an individual investor and focus on investing in dividend-paying and dividend-growing stocks with a long-term horizon. In addition to a DGI portfolio, I manage and invest in a couple of high-income portfolios as well as some Risk-adjusted Rotation Strategies. I believe "Passive Income" is what makes you 'Financially Free'. My personal goal is to generate at least 50% of my retirement income from dividends and rest from other investments like real-estate (rental) etc. I have been investing for the last 25 years and consider myself an experienced investor. I plan to share my experiences by way of writing two or three articles a month and also share my portfolio strategy.
I am currently long on ABT, ABBV, JNJ, PFE, NVS, NVO, CL, CLX, GIS, UL, NSRGY, PG, MON, ADM, MO, PM, KO, DEO, MCD, WMT, WBA, CVS, LOW, CSCO, MSFT, INTC, T, VZ, VTR, CVX, XOM, VLO, HCP, O, OHI, NNN, STAG, WPC, MAIN, NLY, ARCC, PCI, PDI, PFF, RFI, RNP, UTF, EVT, FFC, HQH, KYN, NMZ, NBB, JPS, JRI, TLT.
Kim Klaiman is a full time options trader and founder of SteadyOptions.com. He trades mostly non-directional strategies, like pre-earnings strangles and iron condors. Kim likes to trade strategies with negative correlation. He lives in Toronto, Canada. Visit the SteadyOptions.com forum. SteadyOptions offers a combination of a high quality education and actionable trade ideas using variety of Non-Directional option trading strategies for Steady and Consistent Profits. Email: email@example.com Follow me on Twitter: https://twitter.com/SteadyOptions_ SteadyOptions performance: https://steadyoptions.com/performance
Former broker, now an independent analyst/writer on Seeking Alpha and founder and editor of the Growth Stock Forum. Focusing on small-cap, mid-cap and biotech stocks. Looking for substantial sales and earnings growth potential and seeking the best risk-adjusted returns from my stock selection. Taking advantage of medium to long-term momentum.
My articles represent my personal opinion and analysis and should not be regarded as investment advice in any way. Readers and subscribers should do their own due diligence and/or consult their financial advisor before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.
Exclusive research: http://seekingalpha.com/author/oneil-trader/research
Valuentum (val∙u∙n∙tum) [val-yoo-en-tuh-m] Securities Inc. is an independent investment research publisher, offering premium equity reports, dividend reports, and ETF reports, as well as commentary across all sectors/companies, a Best Ideas Newsletter (spanning market caps, asset classes), a Dividend Growth Newsletter, modeling tools/products, and more. Independence and integrity remain our core, and we strive to be a champion of the investor. Valuentum is based in the Chicagoland area. Valuentum is not a money manager, broker, or financial advisor. Valuentum is a publisher of financial information.
Visit our website at www.valuentum.com
Please read our Disclaimer that applies to all articles published on Seeking Alpha: http://www.valuentum.com/categories/20110613. Follow us on Twitter: @Valuentum
Parsimony Research provides dividend stock research and analysis to investors subscribed to the Dividend Investors Club. The Dividend Investors Club is made up of thousands of do-it-yourself dividend and income investors working toward one common goal...generating consistent income!
Our strategy is simple:
1. Buy great dividend stocks at reasonable prices.
2. Enhance income with conservative option strategies.
3. Manage risk through diversification and exit strategies.
Our research (which includes dividend stock rankings, online stock profiles, Buy Zones, Profit Zones, Action Ratings, stock screens, and model portfolios) will give you all the tools you need to build and monitor your own DIY Dividend Portfolio and super charge that portfolio with conservative option strategies (cover calls and cash-secured puts).
Visit the Dividend investors Club website to learn more...
As director of research at Portfolio123, I have long specialized in rules/factor-based equity investing strategies of the sort characterized as “Smart Alpha” in the July 2014 Journal of Portfolio Management. In addition, I formerly managed a high-yield fixed-income fund and conducted research involving quantitative asset allocation strategies such as are at the foundation of what today has come to be known as Robo Advising. I formerly edited the the Forbes Low Priced Stock Report, and served as an assistant research director at Value Line. I have long had a passion for investor education, which has resulted in my having conducted numerous seminars on stock selection and analysis, and the authoring of two books: Screening The Market and The Value Connection.
Come watch our Introduction video on homepage:
Career experiences of founders: buyside portfolio manager, investment banking, institutional & high net worth asset management, website construction & professional trading. We have no affiliation with any financial institution.
For an independent product review from Stocks & Commodities magazine, copy the entire link below and paste into your browser:
I am a retired (as of September 2001) IT manager. While I have always followed the markets, during my IT career my market research time was limited. Upon retiring, I have focused full-time on the markets and my own market education and growth. I have evolved my investment/trading strategy over the years to the point that I am comfortable with my approach, both from a suitability standpoint and from a results standpoint. In addition to reading and re-reading numerous investment classics, my education has been augmented by my experience, particularly the market declines of 2000-2002 and 2008-2010. I make money from dividends, occasional stock sales, and option sales, either covered calls or cash-covered puts. I only own dividend-paying stocks, and I usually am about 75% invested. I base my investment decisions on both fundamental and technical analysis. While I refer to numerous financial web sites, I spend more than 50% of my research time at Seeking Alpha. In recent years, I have expanded my knowledge to encompass U.S. Income Taxation of investment income, and from there to US Income Taxation overall. As of October 2015, I am an Enrolled Agent, which is recognition granted by the IRS to a tax practioner who has passed three Special Enrollment Examinations (SEE).
The articles I submit will illustrate "hands-on, real world" investment experiences based on my own activities as an independent, small investor, my purpose being to share what I've learned that hopefully will be helpful to others. I will strive to present my thoughts in relatively easy-to-understand terms, and will usually focus on the practical rather than the theoretical.
F.A.S.T. Graphs™ is a powerful research tool providing “essential fundamentals at a glance” on over 17,000 symbols. F.A.S.T. Graphs™ empowers the user to research stocks deeper and faster by allowing them to exploit the undeniable relationship and functional correlation between long-term earnings growth and market price. Warren Buffett, the greatest capital allocator of all time, said; “there are only two things that investor needs to know; how to value a company and how to think about stock prices.” With the F.A.S.T. Graphs™ at their disposal, users are able to perform both of these critical tasks… FAST. F.A.S.T. is an acronym for Fundamentals Analyzer Software Tool that takes all the hours of manual graphing of business fundamentals and reduces it to seconds, giving you critical information in an instant. With one glance you know a lot about the business you are graphing and its past, present and future value. F.A.S.T. Graphs™ should be the first step in every research project. Each graph is worth 1,000 words in describing a company’s growth, consistency and valuation.
Dave Fish is the author of the U.S. Dividend Champions spreadsheet (and PDF), which is updated at the end of each month...and lists companies that have increased their dividend payout for at least 25 consecutive years. (Separate tabs list "Contenders" that have increased their payouts for 10-24 years and "Challengers" that have increased their payouts for 5-9 years.) http://dripinvesting.org/Tools/Tools.asp
I am an individual investor and the author of seven eBooks on dividend growth investing. I try to help self-directed individual investors profit from stock investing. I contribute articles and studies to both Seeking Alpha and Daily Trade Alert. I hold an undergraduate degree in physics from Holy Cross College and a JD from Georgetown University. My wife Sue and I live in beautiful Canandaigua, NY.
Roger Conrad needs no introduction to individual and professional investors, many of whom have profited from his decades of experience uncovering the best dividend-paying stocks for accumulating sustainable wealth.
Roger Conrad founded and ran the Utility Forecaster and Canadian Edge newsletters before leaving to form his own publishing company, Capitalist Times (www.CapitalistTimes.com). During his almost 30-year tenure at Utility Forecaster, Hulbert Financial Digest routinely ranked the publication as one of the best investment newsletters.
His new publication, Conrad’s Utility Investor (www.ConradsUtilityInvestor.com), continues his in-depth coverage and analysis of more than 200 essential-services stocks, primarily utilities and telecoms. Roger Conrad is also an expert on master limited partnerships (MLP) and the Canadian energy sector, which he covers for Energy & Income Advisor (www.EnergyAndIncomeAdvisor.com).
He’s also an independent trustee of Miller/Howard High Income Equity Fund and the author of Power Hungry: Strategic Investing in Telecommunications, Utilities and Other Essential Services. Although he spends a good deal of time in front of a Bloomberg terminal or reading 10-K and 10-Q reports, he’s also an avid outdoorsman and baseball fan.
The masthead may have changed, but readers can count on Roger to deliver the same high-quality analysis and rational assessment of the best dividend-paying utilities, MLPs and dividend-paying Canadian energy names.
My name is Mike McNeil and I’m the author of The Dividend Guy Blog along with the owner and portfolio manager over at Dividend Stocks Rock. I earned my bachelor degree in finance-marketing, own a CFP title along with an MBA in financial services. Besides being a passionate investor, I’m also happily married with three beautiful children.
I started my online venture to educate people about investing and to be able to spend more time with my family.
I used to struggle with the same issues millions of small investors deal with on a daily basis. Which stocks to buy? When to sell them? How to find the time to manage my portfolio? How to diversify? I wasn’t into dividend investing until I looked in depth at my portfolio returns and realized I was having difficulty keeping up with the market.
The root of the problem was a very poorly built portfolio that lacked structure and the components required to build a sturdy base. I made good money from the stock market but I was taking unnecessary risk to achieve my investing goals.
From that point on, I was determined to create a portfolio strategy that would allow me to benefit from dividend growth stocks as a solid foundation. Since then, I manage my portfolio with a stress free method that enables me to cash out dividend payments even when the market goes sour.
Doug K. Le Du is a preferred stock researcher, author of the book titled Preferred Stock Investing, syndicated writer and publisher of three monthly preferred stock newsletters.
Doug has been studying the preferred stock marketplace since 2002. In 2006 he published the first edition of Preferred Stock Investing which has been updated and re-published regularly since then.
Preferred Stock Investing teaches risk-averse investors how to screen, buy and sell the highest quality preferred stocks. The book lists all qualifying preferred stocks that have been issued since January 2001.
The ten selection criteria from Preferred Stock Investing filtered out the 57 preferred stocks from the big banks that would be claimed by the Global Credit Crisis and let pass the 13 issues from the big banks that were saved by acquisition. In 70 out of 70 cases, a 100% success rate for almost two years running, the preferred stock selection criteria found in Preferred Stock Investing protected preferred stock investors.
As a researcher, Doug researches the market price behavior of the highest quality preferred stocks and writes to you about trends and opportunities. His premium subscription service (described at www.PreferredStockInvesting.com) providers subscribers with email alerts of new preferred stock issues, access to his preferred stock catalogs and HotLists, a monthly newsletter just for premium subscribers and much more.
Doug's academic background is in economics and statistics. Doug retired from his position as Managing Director at one of the world's largest management consulting firms in 2002 to focus on preferred stock research. Doug does not sell preferred stocks nor is he a stock broker or financial adviser.
In the early 1990s, during the middle of a secular bull market, I began work on "A Modern Approach To Graham and Dodd Investing," that was not particularly suited for the decade of the 1990s, but was ideally suited for the following "Lost Decade" of the 2000s.
John P. Reese is considered an expert in the systematic investing strategies of legendary investors, including Peter Lynch, Ben Graham, Warren Buffett and others. He has been active in the development of fundamentally-based quantitative models since the mid-90s. His research on Seeking Alpha will include stock ideas, strategy and value investing pieces, behavioral finance concepts, systematic and modeling methods as well as other long term investing concepts.
John is founder and CEO of Validea.com and also co-founder of Validea Capital Management. Validea Capital runs an actively managed ETF that utilizes the fundamental stock selection models of investing legends as well as a set of robo advisor allocations through Validea Legends and Validea Legends Income.
John holds two U.S. patents in the area of automated stock analysis and is considered an expert in the field of quantitative stock selection using the strategies of investing legends.
John is a columnist for TheStreet.com, Forbes.com and Canada's Globe & Mail and is co-author of “The Guru Investor: How to Beat the Market Using History’s Best Investment Strategies". He holds a master's of business administration from Harvard Business School and a degree in computer science from MIT.
A more complete biography can be found here: http://en.wikipedia.org/wiki/John_P._Reese
I am a freelance author and model developer. I currently work as a consultant for a couple of select firms designing ETF asset allocation models and small-cap systems.
If your firm is looking for a research consultant on a casual or part-time basis - please reach out to me. I have some very high performing small-cap models that may interest you. I also design custom models to fit any of your needs upon request.
Contact me directly at firstname.lastname@example.org
I write about dividend growth stocks on my website http://www.dividendgrowthinvestor.com/. I am mostly a buyer of high quality dividend stocks, with solid competitive advantages. My holding period is forever, as long as the dividend is at least maintained. I tend to concentrate my efforts on stocks which grow earnings and dividends, which provides outstanding total returns over time. I only focus my attention to stocks with sustainable dividend payments. I am also a firm believer in diversification accross sectors and geographic locations. I have been focusing my attention particularly to companies that regularly increase dividends to their shareholders since 2007. On my blog I share my thoughts on investing in dividend paying stocks that have consistently increased their payments over time and tips on growing my dividend income. I hope that my blog will serve as an inspiration for my readers and that it would change their financial lives for the better. Visit my website, Dividend Growth Investor (http://www.dividendgrowthinvestor.com/)